Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Openshaw

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
The Lancet. Respiratory Medicine|April 10, 2022
Inhaled corticosteroids: not just for asthma, but for COVID-19?Felicity Liew, Peter J M Openshaw
Thorax|June 5, 2010
Impact of the 2009 influenza pandemicJ Dunning, P J M Openshaw
Lancet (London, England)|July 25, 2006
BronchiolitisRosalind L Smyth, Peter J M Openshaw
Clinical Microbiology Reviews|July 16, 2005
Immune responses and disease enhancement during respiratory syncytial virus infectionPeter J M Openshaw, John S Tregoning
Current Opinion in Infectious Diseases|October 23, 2012
Benefit and harm from immunity to respiratory syncytial virus: implications for treatmentMaximillian S Habibi, Peter J M Openshaw
Expert Opinion on Investigational Drugs|June 4, 2004
Vaccines for the prevention of respiratory viral infections: problems and current statusWieslawa Olszewska, Rebecca Helson, Peter J M Openshaw
Viral Immunology|December 20, 2005
RSV 2005: Global impact, changing concepts, and new challengesPeter J M Openshaw, John Tregoning, James Harker
British Medical Bulletin|August 15, 2002
Development of vaccines against common coldsWieslawa Olszewska, Maria Zambon, Peter J M Openshaw
The European Respiratory Journal|March 23, 2023
Long COVID: clues about causesFelicity Liew, Claudia Efstathiou, Peter J M Openshaw
Clinics in Chest Medicine|February 5, 2017
Vaccines in the Prevention of Viral PneumoniaClementine S Fraser, Akhilesh Jha, Peter J M Openshaw
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
The Lancet. Respiratory Medicine|April 10, 2022
Inhaled corticosteroids: not just for asthma, but for COVID-19?Felicity Liew, Peter J M Openshaw
Thorax|June 5, 2010
Impact of the 2009 influenza pandemicJ Dunning, P J M Openshaw
Lancet (London, England)|July 25, 2006
BronchiolitisRosalind L Smyth, Peter J M Openshaw
Clinical Microbiology Reviews|July 16, 2005
Immune responses and disease enhancement during respiratory syncytial virus infectionPeter J M Openshaw, John S Tregoning
Current Opinion in Infectious Diseases|October 23, 2012
Benefit and harm from immunity to respiratory syncytial virus: implications for treatmentMaximillian S Habibi, Peter J M Openshaw
Expert Opinion on Investigational Drugs|June 4, 2004
Vaccines for the prevention of respiratory viral infections: problems and current statusWieslawa Olszewska, Rebecca Helson, Peter J M Openshaw
Viral Immunology|December 20, 2005
RSV 2005: Global impact, changing concepts, and new challengesPeter J M Openshaw, John Tregoning, James Harker
British Medical Bulletin|August 15, 2002
Development of vaccines against common coldsWieslawa Olszewska, Maria Zambon, Peter J M Openshaw
The European Respiratory Journal|March 23, 2023
Long COVID: clues about causesFelicity Liew, Claudia Efstathiou, Peter J M Openshaw
Clinics in Chest Medicine|February 5, 2017
Vaccines in the Prevention of Viral PneumoniaClementine S Fraser, Akhilesh Jha, Peter J M Openshaw
Pageof 18